Benesis Commences Commercial Manufacturing of Plasma Derivative Products at Its Osadano Plant.
Tokyo, Japan, Oct 20, 2005 - (JCNN JCNN Japan Corporate News Network ) - Benesis, a consolidated
subsidiary of Mitsubishi Pharma Mitsubishi Pharma Corporation (三菱ウェルファーマ株式会社, , has started manufacturing plasma
derivative derivative: see calculus.
derivative
In mathematics, a fundamental concept of differential calculus representing the instantaneous rate of change of a function. products on a commercial basis at its Osadano plant in Kyoto.
Presently the company manufactures all of its plasma derivative
products at the plant as it will close its Yodogawa plant in Osaka by
year-end.
With the move, the company aims to improve manufacturing
productivity and increase the safety and reliability of the products.
Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights
reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion